Results per Page:
Fred Hutch Cancer Center announces 2025 Evergreen Fund awardees
Nine Fred Hutch researchers receive funding totaling $1.175 million for projects with commercial partnership potential
Mapping the secretory phenotype of senescent colon fibroblasts
From the Grady lab, Translational Science and Therapeutics, and Public Health Sciences Divisions
Clinical study of a blood test shows 83% accuracy for detecting colorectal cancer
The New England Journal of Medicine published findings of a blood test for detecting circulating tumor DNA in people with average risk of colorectal cancer
(Bio)marking the spot – utilizing droplet digital PCR for risk biomarker identification in colorectal cancer
From the Grady Lab, Translational Science and Therapeutics
Large-scale study led by Fred Hutch finds new genetic risk factors for colorectal cancer, paving the way for better screening, prevention
Collaborative effort with global scientific investigators yields new insights into commonly diagnosed disease
Biomarker discovery for the early detection of esophageal adenocarcinoma and high-grade dysplasia
From the Grady Lab, Clinical Research Division
Fred Hutch Evergreen Fund awards six grants to promising projects
Scientists receive up to $200K to boost research for projects deemed to have partnership potential
Esophageal adenocarcinoma: when DNA methylation informs the treatment
from the Grady lab, Clinical Research Division
6 misconceptions about colorectal cancer
Get the facts and lower your risk
Fred Hutch researcher receives grant for esophageal cancer screening study
Incidence of esophageal cancer has increased fivefold since the 1970s
Glory's gift: Colon cancer patient's enduring legacy
A young woman’s resolve to help find a better way to detect colon cancer led to a years-long relationship between her family and a researcher across the country
The bottom line on colon cancer: Get screened
March is National Colorectal Cancer Awareness Month
Early detection efforts yield nearly $17 million
Awards fund network coordination and biomarker discovery, validation
A comfortable colorectal test
Clinical researcher William Grady aims to improve colorectal-cancer survival by developing a screening test people are more likely to undergo